Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America
Jeremy B SwannMark J Smyth

Abstract

Here we report the effects of loss of the Toll-like receptor-associated signaling adaptor myeloid-differentiation factor 88 (MyD88) on tumor induction in two distinct mouse models of carcinogenesis. The 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol 13-acetate (TPA)-induced skin papilloma model depends on proinflammatory processes, whereas the 3'-methylcholanthrene (MCA) induction of fibrosarcoma has been used by tumor immunologists to illustrate innate and adaptive immune surveillance of cancer. When exposed to a combination of DMBA/TPA, mice lacking MyD88 formed fewer skin papillomas than genetically matched WT controls treated in a similar manner. Unexpectedly, however, fewer MyD88-/- mice formed sarcomas than WT controls when exposed to MCA. In contrast, MyD88-deficient mice did not show a defective ability to reject highly immunogenic transplanted tumors, including MCA sarcomas. Despite the reported role of TNF in chronic inflammation, TNF-deficient mice were significantly more susceptible to MCA-induced sarcoma than WT mice. Overall, these data not only confirm the key role that MyD88 plays in promoting tumor development but also demonstrate that inflammation-induced carcinogenesis and cancer immunoeditin...Continue Reading

References

Feb 24, 2000·The Journal of Experimental Medicine·M J SmythD I Godfrey
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M J SmythS E Street
Sep 22, 2001·Science·M GirardiA C Hayday
Jan 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Erika CretneyMark J Smyth
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Feb 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Elena VoronovRon N Apte
May 7, 2003·The Journal of Experimental Medicine·Thomas EnzlerGlenn Dranoff
Jan 31, 2004·Seminars in Immunology·Kiyoshi Takeda, Shizuo Akira
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Aug 17, 2004·Immunity·Gavin P DunnRobert D Schreiber
Sep 17, 2004·Cell·Hans Clevers
Sep 24, 2004·Nature·Philip A BeachyDavid M Berman
Mar 16, 2005·Cancer Cell·Frances BalkwillAlberto Mantovani
Mar 31, 2005·Advances in Cancer Research·Stephen C Robinson, Lisa M Coussens
Sep 1, 2005·The Journal of Experimental Medicine·Mark J SmythYoshihiro Hayakawa
Mar 11, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Margareta M Mueller
May 12, 2006·Nature·John L LangowskiMartin Oft
Aug 22, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joseph A Hollenbaugh, Richard W Dutton
Feb 24, 2007·Nature Reviews. Immunology·Giorgio Trinchieri, Alan Sher
Jun 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeremy B SwannMark J Smyth
Jul 7, 2007·Science·Seth Rakoff-Nahoum, Ruslan Medzhitov

❮ Previous
Next ❯

Citations

Aug 26, 2009·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Matthew R ThompsonBryan R G Williams
Oct 28, 2010·Cancer Immunology, Immunotherapy : CII·Salomé González-ReyesFrancisco J Vizoso
May 11, 2013·Trends in Immunology·Rosalba SalcedoGiorgio Trinchieri
May 18, 2013·Cell Death & Disease·M-f HeX-n Wang
Sep 27, 2012·Immunology and Cell Biology·Melvyn T ChowMark J Smyth
Jul 3, 2013·Immunology and Cell Biology·Amitabha ChaudhuriAvi Ashkenazi
Dec 5, 2008·Nature Reviews. Cancer·Seth Rakoff-Nahoum, Ruslan Medzhitov
Apr 4, 2009·Nature Reviews. Cancer·Frances Balkwill
Nov 26, 2008·Nature Reviews. Immunology·David M Mosser, Justin P Edwards
Oct 28, 2008·Proceedings of the National Academy of Sciences of the United States of America·Alexander J MullerAndrew L Mellor
Mar 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ami NabeyamaMasato Tanaka
Apr 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michele W L TengMark J Smyth
Apr 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·John StaggMark J Smyth
Nov 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kathleen M KokolusElizabeth A Repasky
Feb 13, 2008·The Journal of Experimental Medicine·Michael Dougan, Glenn Dranoff
Jul 14, 2010·The Journal of Experimental Medicine·Rosalba SalcedoGiorgio Trinchieri
Aug 22, 2012·The Journal of Experimental Medicine·Christophe CataissonGiorgio Trinchieri
Aug 22, 2012·The Journal of Experimental Medicine·Atsuo OchiGeorge Miller
Dec 24, 2009·Carcinogenesis·Armando RojasErik Morales
Oct 29, 2008·Acta Pharmacologica Sinica·Xia Wang, Yong Lin
Nov 15, 2008·Annual Review of Immunology·Michael Dougan, Glenn Dranoff
May 6, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Meghan B DavisYoung J Kim
Oct 14, 2010·The Journal of Clinical Investigation·Isabelle CosteToufic Renno
May 4, 2011·The Journal of Clinical Investigation·Michael DouganGlenn Dranoff
Oct 16, 2012·The Journal of Clinical Investigation·Xueqiang ZhaoZhihai Qin
Mar 5, 2013·The Journal of Clinical Investigation·Deborah A KnightMark J Smyth
Dec 7, 2010·BMC Cancer·Salomé González-ReyesFrancisco J Vizoso
Apr 27, 2012·Journal of Translational Medicine·Yi ZhuBi-Fang Deng
Oct 4, 2013·Immunotherapy·Roheena Z PanniDavid G DeNardo
Nov 16, 2010·Clinical & Developmental Immunology·Yolanda Nesbeth, Jose R Conejo-Garcia
Jul 11, 2008·PPAR Research·Jo A Van GinderachterPatrick De Baetselier
Aug 13, 2013·Oncogene·J-P PradereR F Schwabe
Jul 11, 2012·European Journal of Nuclear Medicine and Molecular Imaging·Valentina Di GialleonardoErik F J de Vries

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.